Clinical Trial Update: Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating atorvastatin to prevent metastasis in patients with resected high-risk cutaneous melanoma (stages IIA, IIB, IIIA); the study is ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING